Facing a mesothelioma diagnosis is incredibly tough, and it’s crucial for patients and their families to receive support, accurate information, and hope. As you encounter difficult choices about medical, financial, and legal matters in the months following diagnosis, our FAQ resource can help guide you through these decisions. Find the resource here:
Shepard O'Donnell的动态
最相关的动态
-
Are you overwhelmed with the many difficult medical, financial, and legal decisions that come with a mesothelioma diagnosis? We’ve compiled a helpful FAQ resource that answers some of the questions we often hear. Download the resource here. https://buff.ly/3TjSth8 #mesothelioma #asbestos
Mesothelioma Free Guide Request Form
https://shepardlawfirm.com
要查看或添加评论,请登录
-
We looked at data from over 30 hospitals in the U.S. to uncover: Who is typically responsible for the morning patient assignment/distribution processes? Which factors are most important to them when creating rounding lists? How many hospitals prioritize geography over continuity of care? How many evenly balance patients amongst hospitalists? What unique ways are hospitals creating their patient assignments that we can learn from? Here's what we discovered: https://lnkd.in/dbeZZQ5i
Patient Assignment Benchmark Report 2024 - medaptus
https://www.medaptus.com
要查看或添加评论,请登录
-
Let Caligor Coghlan craft the perfect solution for your clinical trial supply needs. Meet our team of experts at the conferences below, or follow the link to book a meeting with our Head of Clinical Supply Solutions. #clinicalsupplyservices #clinicaltrialsupply #optimizingtheclinicalsupplychain #clinicalresearch
Contact Us | Clinical Trial Supply Solutions | CalCog
https://calcog.com
要查看或添加评论,请登录
-
?? Calling all healthcare professionals??? We’re on the hunt for participants in an online survey about the use of risk assessments in the treatment of patients with cardiovascular diseases.? ? Want to contribute? The survey takes around 10 minutes to complete, and will help us reach our goal of identifying the primary methods and challenges associated with risk assessments related to cardiovascular diseases. This will contribute to our broader work towards creating an AI-powered tool incorporating diverse real-world data sources to aid in the diagnosis, treatment, and risk assessment of cardiovascular diseases. Take the survey here: https://lnkd.in/dgytkSCa #CVD #cardiovascularcare #healthcare #healthcareprofessionals #medicine #biotech?
T2.1 Questionnaire
ec.europa.eu
要查看或添加评论,请登录
-
What do you think about integration of AI in clinical risk stratification tools?
?? Calling all healthcare professionals ?? We're looking for participants in an online survey about the use of risk assessments, especially in the treatment of patients with cardiovascular diseases. Want to contribute? The survey takes around 10 minutes to complete, and will help us reach our goal of identifying the primary methods and challenges associated with risk assessments related to cardiovascular diseases. This will contribute to our broader work towards creating an AI-powered tool incorporating diverse real-world data sources to aid in the diagnosis, treatment, and risk assessment of cardiovascular diseases. Here's the link to the survey: https://lnkd.in/dgytkSCa #cardiovasculardiseases #CVD #cardiovascularcare #medtech #healthcare #AI #data
T2.1 Questionnaire
ec.europa.eu
要查看或添加评论,请登录
-
Reminder: We're looking for healthcare professionals to participate in a brief online survey about risk assessments in cardiovascular care! Check out the details below ??
?? Calling all healthcare professionals ?? We're looking for participants in an online survey about the use of risk assessments, especially in the treatment of patients with cardiovascular diseases. Want to contribute? The survey takes around 10 minutes to complete, and will help us reach our goal of identifying the primary methods and challenges associated with risk assessments related to cardiovascular diseases. This will contribute to our broader work towards creating an AI-powered tool incorporating diverse real-world data sources to aid in the diagnosis, treatment, and risk assessment of cardiovascular diseases. Here's the link to the survey: https://lnkd.in/dgytkSCa #cardiovasculardiseases #CVD #cardiovascularcare #medtech #healthcare #AI #data
T2.1 Questionnaire
ec.europa.eu
要查看或添加评论,请登录
-
Revolutionize sepsis diagnostics with PATHFAST?! Swift, accurate results in minutes, empowering healthcare for better patient outcomes. https://lnkd.in/gNTRTmRE
Revolutionize sepsis diagnostics with PATHFAST?! Swift, accurate results in minutes, empowering healthcare for better patient outcomes. https://lnkd.in/gNTRTmRE
Sepsis Marker | PATHFAST?| Discover More
phchd.com
要查看或添加评论,请登录
-
?? Calling all healthcare professionals ?? We're looking for participants in an online survey about the use of risk assessments, especially in the treatment of patients with cardiovascular diseases. Want to contribute? The survey takes around 10 minutes to complete, and will help us reach our goal of identifying the primary methods and challenges associated with risk assessments related to cardiovascular diseases. This will contribute to our broader work towards creating an AI-powered tool incorporating diverse real-world data sources to aid in the diagnosis, treatment, and risk assessment of cardiovascular diseases. Here's the link to the survey: https://lnkd.in/dgytkSCa #cardiovasculardiseases #CVD #cardiovascularcare #medtech #healthcare #AI #data
T2.1 Questionnaire
ec.europa.eu
要查看或添加评论,请登录
-
Do you have an interest in participating in clinical research but aren't sure where to start? Join our network of esteemed healthcare providers today! When you join our network, you can participate in patient identification programs to help support clinical research studies that target your patient population.? Click the link below for more information! https://lnkd.in/gJvvF6rM ? #clinicaltrials?#healthcareproviders?#physiciannetwork?#researchopportunity?#medicaladvancements?#researchspecialist?#pcp?#specialist?#clinicaltrialrecruitment?#research?#trials?#hcps?#hcpnetwork
Click here for more info!
https://www.effectusctr.com
要查看或添加评论,请登录
-
?? Just added! Mackillop et al. quantify environmental impacts of three multicentre late phase clinical trials: 527—2,452 kgCO2e per randomized patient! ?? it at: healthcarelca.com/gallery. #sustainablehealthcare
Environmental impacts of clinical trials.
healthcarelca.com
要查看或添加评论,请登录